It noted that the company's market capitalization has swelled to more than $20 million from about $3 million over the last 15 years, and its stock price also has soared over the longer time frame. "During Mr. Coury's long tenure, Mylan has …
Lawmakers seethed, parents broke into tears at pharmacy counters, regulators opened investigations, competitors raced to come up with cheaper alternatives, and Mylan’s stock tumbled 29 percent. Further Reading Rage mounts against …
The generic drug company's move is a blow to the Tel Aviv Stock Exchange's recovery prospects. Generic drugs company Mylan has announced its intention of delisting from the Tel Aviv Stock Exchange. Mylan has been traded in Tel Aviv …
Mylan NV shares rose 2.8% in premarket trade Tuesday after the company reported a first-quarter profit beat and revenue miss. Earnings for the latest quarter rose to $66.4 million, or 12 cents per share, from $13.9 million, or 3 cents per …
Mylan's shares dropped after it said that delays in launching key new drugs and lower prices for generics in the United States will hurt its profitability this and next year. Fred Katayama reports. Mylan's stock plunged after the maker of Epi …
Mylan N.V. MYL is scheduled to report first-quarter 2017 results on May 10, before the market opens. The company’s performance has been mixed so far, having beaten earnings estimates in three of the trailing four quarters and missing …
Mylan N.V. (MYL) cut its 2017 guidance, as a result of expected delays in the timing of certain key new product launches. In the Wednesday's pre-market trade, MYL is trading at $28.90, down $2.89 or 9.09 percent. The company now …
* Mylan NV - ‍announced it is voluntarily delisting company’s ordinary shares from trading on tel aviv stock exchange * Mylan NV - ‍ delisting of Mylan’s ordinary shares from tase will become effective in three months, on February 12, 2018 ...